ExpressCells delivers customized stable cells with specific reporter genes using CRISPR/cas9 technology.

ExpressCells speeds drug delivery and biological research via genetic engineering to produce custom cell lines. We use CRISPR plus our proprietary genetic vector system to create custom cells for research 75% faster than current technology. Our living cells can replicate diseases or have proteins glow in multiple colors.

Sector: Healthcare
Sub Sector: Pharma
Industry: Biotechnology
Status: Active
County: Philadelphia

Contact Information

Matt Handel

CEO & Co-Founder

Oscar Perez-Leal, MD

Co-Founder & Scientific Adviser

David Becker, MD

Commercial Lead